PropolisvsResveratrol

CAPE (caffeic acid phenethyl ester) inhibits NF-kappa B nuclear translocation by preventing I-kappa B alpha degradation and blocking p65/p50 nuclear import — suppresses TNF-alpha, IL-1beta, IL-6, COX-2 transcription. Flavonoids (chrysin, pinocembrin, galangin) provide antioxidant protection through free radical scavenging and metal chelation. Bacteriostatic and bactericidal against Cutibacterium acnes and Staphylococcus aureus via cell wall disruption and protein synthesis inhibition. Promotes wound healing: stimulates fibroblast collagen I/III synthesis, keratinocyte migration (integrins, matrix metalloproteinases), angiogenesis. Inhibits hyaluronidase, preserving skin hyaluronic acid. Effective for acne (reduces inflammation, bacterial load) and sensitive skin (calming barrier disruption).

Resveratrol activates SIRT1 (sirtuin 1), a NAD+-dependent deacetylase that deacetylates histones and non-histone targets including p53, FOXO transcription factors, and NF-κB, regulating cellular stress response, DNA repair, autophagy, and inflammatory pathways in keratinocytes and fibroblasts. It scavenges superoxide anion, hydroxyl radical, and metal-induced free radicals through its phenolic hydroxyl groups. Resveratrol inhibits NF-κB nuclear translocation and downstream cytokine production (TNF-α, IL-1β, IL-6), reducing UV-induced inflammation. It inhibits tyrosinase (mild brightening), matrix metalloproteinase-9 (MMP-9, gelatinase B) to prevent collagen and elastin breakdown, and AP-1 (c-Fos/c-Jun) to reduce photoaging-related gene expression. It may also activate Nrf2, upregulating antioxidant enzymes (HO-1, NQO1). Topical application achieves higher skin tissue concentrations than oral supplementation due to first-pass metabolism. Stability is improved in anhydrous or encapsulated formulations.